Skip to main content

Advertisement

Log in

Quantitative HHV-6B antigenemia test for the monitoring of transplant patients

  • Brief Report
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

Abstract

Human herpesvirus-6 (HHV-6) infection, mostly caused by variant B, is common after transplantation. Here, we report a new modified method using an HHV-6B glycoprotein IgG antibody, OHV-3, and attempt to quantify the HHV-6 antigenemia after liver transplantation. Twenty-four liver transplant recipients were frequently monitored by the HHV-6 antigenemia test, which detects the HHV-6B virion protein in peripheral blood mononuclear cells (PBMC). HHV-6B antigens were now retrospectively demonstrated using a glycoprotein OHV-3 IgG antibody in the immunoperoxidase staining from the same specimens and quantified as positive cells/10,000 PBMC. The results were confirmed and quantified by DNA hybridization in situ. Altogether, 206 blood specimens were analyzed. During the first six months, HHV-6 antigenemia was detected in 17/24 (71%) recipients by using the HHV-6B virion antibody. In total, 37% (77/206) of specimens were positive with the virion antibody and 39% (78/201) by the OHV-3 antibody. The peak number of OHV-3-positive cells in the PBMC varied from 5 to 750/10,000 (mean 140/10,000). The OHV-3 antibody was useful to quantify the HHV-6B antigenemia. The findings of the HHV-6B quantitative antigenemia using the OHV-3 antibody correlated well with the previous qualitative HHV-6 antigenemia assay, and can be used as an alternative quantitative method in the monitoring of HHV-6 in transplant patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. De Bolle L, Naesens L, De Clercq E (2005) Update on human herpesvirus 6 biology, clinical features, and therapy. Clin Microbiol Rev 18:217–245

    Article  PubMed  Google Scholar 

  2. Ljungman P, Singh N (2006) Human herpesvirus-6 infection in solid organ and stem cell transplant recipients. J Clin Virol 37(Suppl 1):S87–S91

    Article  CAS  PubMed  Google Scholar 

  3. Zerr DM (2006) Human herpesvirus 6: a clinical update. Herpes 13(1):20–24

    PubMed  Google Scholar 

  4. Abdel Massih RC, Razonable RR (2009) Human herpesvirus 6 infections after liver transplantation. World J Gastroenterol 15(21):2561–2569

    Article  PubMed  Google Scholar 

  5. Ward KN, Leong HN, Nacheva EP, Howard J, Atkinson CE, Davies NW, Griffiths PD, Clark DA (2006) Human herpesvirus 6 chromosomal integration in immunocompetent patients results in high levels of viral DNA in blood, sera, and hair follicles. J Clin Microbiol 44:1571–1574

    Article  CAS  PubMed  Google Scholar 

  6. Loginov R, Härmä M, Halme L, Höckerstedt K, Lautenschlager I (2006) HHV-6 DNA in peripheral blood mononuclear cells after liver transplantation. J Clin Virol 37(Suppl 1):S76–S81

    Article  CAS  PubMed  Google Scholar 

  7. Lautenschlager I, Linnavuori K, Höckerstedt K (2000) Human herpesvirus-6 antigenemia after liver transplantation. Transplantation 69:2561–2566

    Article  CAS  PubMed  Google Scholar 

  8. Volin L, Lautenschlager I, Juvonen E, Nihtinen A, Anttila VJ, Ruutu T (2004) Human herpesvirus 6 antigenaemia in allogeneic stem cell transplant recipients: impact on clinical course and association with other beta-herpesviruses. Br J Haematol 126:690–696

    Article  PubMed  Google Scholar 

  9. Härmä M, Loginov R, Piiparinen H, Halme L, Höckerstedt K, Lautenschlager I (2005) HHV-6-DNAemia related to CMV-DNAemia after liver transplantation. Transplant Proc 37:1230–1232

    Article  PubMed  Google Scholar 

  10. Okuno T, Sao H, Asada H, Shiraki K, Takahashi M, Yamanishi K (1990) Analysis of a glycoprotein of human herpesvirus 6 (HHV-6) using monoclonal antibodies. Virology 176(2):625–628

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We want to acknowledge the support of the HHV-6 Foundation for providing the OHV-3 MAB, the hybridoma, which was donated by Prof. K. Yamanishi. The OHV-3 monoclonal antibody is available, free of charge, to other transplantation investigators for research purposes from the HHV-6 Foundation Reagents Repository.

This study was supported by grants from the Sigrid Jusélius Foundation (to K. Höckerstedt and I. Lautenschlager) and the Helsinki University Hospital Research Funds (to I. Lautenschlager).

The authors thank Marjatta Palovaara for the technical assistance and Stephen Venn and Courtney Devin for correcting the English text.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R. Loginov.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Loginov, R., Karlsson, T., Höckerstedt, K. et al. Quantitative HHV-6B antigenemia test for the monitoring of transplant patients. Eur J Clin Microbiol Infect Dis 29, 881–886 (2010). https://doi.org/10.1007/s10096-010-0923-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-010-0923-1

Keywords

Navigation